Author(s): Prasad J. Rodge, Mansi B. Rawal, Vinit S. Khairnar

Email(s): nitingosavi2000@gmail.com

DOI: 10.52711/2321-5836.2022.00034   

Address: Prasad J. Rodge, Mansi B. Rawal, Vinit S. Khairnar
Dipartment, Ahinsa Institute of Pharmacy, Dondaicha 425408.
*Corresponding Author

Published In:   Volume - 14,      Issue - 3,     Year - 2022


ABSTRACT:
Omicron was first identified in Botswana earlier in November. It was reported to World Health Organization (WHO) from South Africa on November 24, 2021, which was designated as a variant of concern (VOC) on November 26, 2021.The Omicron variant is thought to be at least three times more infectious than the original SARS-CoV-2 and possibly more so than the delta variant. Omicron contains a large number of mutations that were previously reported in other VOCs including at least 32 mutations in the spike protein alone compared to the 16 mutations in the already highly infectious delta variant. europe’s first case of the variant was confirmed in Belgium on 26 November in a person who tested positive for covid-19 on 22 November. By 29 November cases had been reported in the Netherlands, France, Germany, Portugal, and Italy. The UK had recorded nine cases by the morning of 29 November, six of them in Scotland. According to Brihan Mumbai Municipal Corporation (BMC), a 37-year-old man, who landed in Mumbai from South Africa on November 25, was found infected with Omicron along with one of his contacts - a 36-year-old female friend who arrived in the city from the US the same day.


Cite this article:
Prasad J. Rodge, Mansi B. Rawal, Vinit S. Khairnar. Omicron variant [2021-2022]: A new chapter in the COVID-19 Pandemic. Research Journal of Pharmacology and Pharmacodynamics.2022;14(3):191-5. doi: 10.52711/2321-5836.2022.00034

Cite(Electronic):
Prasad J. Rodge, Mansi B. Rawal, Vinit S. Khairnar. Omicron variant [2021-2022]: A new chapter in the COVID-19 Pandemic. Research Journal of Pharmacology and Pharmacodynamics.2022;14(3):191-5. doi: 10.52711/2321-5836.2022.00034   Available on: https://rjppd.org/AbstractView.aspx?PID=2022-14-3-12


REFERENCE:
1.    Characteristics of Omicron, a New Coronavirus-19 Variant.Author. Hayk S. Arakelyan. Full Professor in Medicine, Doctor of Medical Sciences, Ph. D, Grand Ph. D .Senior Expert of Interactive Clinical Pharmacology , Drug Safety,Treatment Tactics, General Medicine and Clinical Research.President of Rare and Incurable Diseases Association.Yerevan-Armenia, Tokyo-Japan.
2.    Omicron variant (B.1.1.529) of SARS-CoV-2: Threat assessment and plan of action; O.P. Choudhary: College of Veterinary Sciences and Animal Husbandry, Manish Dhawan: Punjab Agricultural University; Priyanka Choudhary: MJF    College of Veterinary and Animal Sciences Jaipur.
3.    www.whop.int ; Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern
4.    Indianexpress.com; Omicron Coronavirus India Highlights, December 19: Tanzanian student studying in Rajkot university tests positive for Omicron; Updated: December 20, 2021.
5.    Ceylontoday.lk; will new measures against omicron work?; published Nov 28 2021.
6.    Dmerhaeyana.org; Omicron COVID Variant Symptoms, Cause, Precaution & Treatment; December 22, 2021.
7.    http://dx.doi.org/10.1136/bmj.n2943; Published: 29 November 2021; Ingrid Torjesen; Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear.
8.    Omicron: A variant of concern; https://www.researchgate.net/publication/357013350
9.    Thehindu.com; fresh cases in Maharashtra Gujarat take India Omicron tally to 4; Jacob Koshy, Mahesh Langa, Alok Deshpande.
10.    www.timesnownews.com ; How to pronounce Omicron, the new COVID- 19 Variant.
11.    COVID-19- Wikipedia; https://images.app.goo.gl/4fThNqHCCUFn5S2L7
12.    www.unicef.org ; What we know about the Omicron variant; 17 December 2021
13.    Cdc.gov; SARS-CoV-2 Variant Classifications and Definitions; Updated Dec. 1, 2021
14.    SARS-CoV-2 Omicron variant: Characteristics and prevention; Xuemei He, Weiqi Hong, Xiangyu Pan, Guangwen Lu, XiaweiWei; MedComm; Accepted: 7 December 2021.
15.    Symptoms of COVID-19; https://www.cdc.gov/; Updated Feb. 22, 2021

Recomonded Articles:

Author(s): Ganesh G. Dhakad, Rohit V. Patil, Tejas I. Chaudhari, Paresh A. Patil.

DOI: 10.52711/2321-5836.2021.00030         Access: Open Access Read More

Author(s): Ghanshyam Sevak, Yashpal Singh Chauhan, Narendra Parihar, Mahendra Singh Rathore

DOI: 10.52711/2321-5836.2022.00018         Access: Closed Access Read More

Author(s): Kavita Sekhri, Sangeeta Bhanwra, Ruchika Nandha, Suruchi Aditya, Deepak Bhasin

DOI: 10.52711/2321-5836.2022.00019         Access: Closed Access Read More

Author(s): Prasad J. Rodge, Mansi B. Rawal, Vinit S. Khairnar

DOI: 10.52711/2321-5836.2022.00034         Access: Closed Access Read More

Research Journal of Pharmacology and Pharmacodynamics (RJPPD) is an international, peer-reviewed journal....... Read more >>>

RNI: Not Available                     
DOI: 10.5958 2321-5836 


Recent Articles




Tags